Use for novel chemokine-binding protein designated A41L, and chemokine-binding fragments thereof, for the treatment of conditions such as inflammation. The A41L protein binds to chemokines in the CXC group.

 
Web www.patentalert.com

< Lentiviral packaging constructs

> Janus family kinases and identification of immune modulators

~ 00441